[go: up one dir, main page]

DE69821001D1 - Wässriges arzneimittel, das einen in wasser sehr schwerlöslichen aktivbestandteil enthält - Google Patents

Wässriges arzneimittel, das einen in wasser sehr schwerlöslichen aktivbestandteil enthält

Info

Publication number
DE69821001D1
DE69821001D1 DE69821001T DE69821001T DE69821001D1 DE 69821001 D1 DE69821001 D1 DE 69821001D1 DE 69821001 T DE69821001 T DE 69821001T DE 69821001 T DE69821001 T DE 69821001T DE 69821001 D1 DE69821001 D1 DE 69821001D1
Authority
DE
Germany
Prior art keywords
water
active ingredient
product containing
slightly soluble
medicinal product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69821001T
Other languages
English (en)
Other versions
DE69821001T2 (de
Inventor
Giovanni Cavallo
Leonardo Marchitto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angelini Acraf SpA
Original Assignee
Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco ACRAF SpA filed Critical Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Application granted granted Critical
Publication of DE69821001D1 publication Critical patent/DE69821001D1/de
Publication of DE69821001T2 publication Critical patent/DE69821001T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69821001T 1997-02-20 1998-02-12 Wässriges arzneimittel, das einen in wasser sehr schwerlöslichen aktivbestandteil enthält Expired - Lifetime DE69821001T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT97MI000363A IT1289939B1 (it) 1997-02-20 1997-02-20 Composizione farmaceutica acquosa comprendente un principio attivo altamente insolubile in acqua
ITMI970363 1997-02-20
PCT/EP1998/000816 WO1998036735A1 (en) 1997-02-20 1998-02-12 Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water

Publications (2)

Publication Number Publication Date
DE69821001D1 true DE69821001D1 (de) 2004-02-12
DE69821001T2 DE69821001T2 (de) 2004-11-11

Family

ID=11376099

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69821001T Expired - Lifetime DE69821001T2 (de) 1997-02-20 1998-02-12 Wässriges arzneimittel, das einen in wasser sehr schwerlöslichen aktivbestandteil enthält

Country Status (26)

Country Link
US (1) US6337087B1 (de)
EP (1) EP0973505B1 (de)
JP (1) JP4299369B2 (de)
KR (1) KR100515249B1 (de)
CN (1) CN1135969C (de)
AR (1) AR011682A1 (de)
AT (1) ATE257374T1 (de)
AU (1) AU740619B2 (de)
BG (1) BG64367B1 (de)
CA (1) CA2285985C (de)
CZ (1) CZ296700B6 (de)
DE (1) DE69821001T2 (de)
DK (1) DK0973505T3 (de)
EA (1) EA002281B1 (de)
ES (1) ES2213894T3 (de)
GE (1) GEP20022751B (de)
HU (1) HU225594B1 (de)
IL (2) IL131354A0 (de)
IT (1) IT1289939B1 (de)
PL (1) PL190987B1 (de)
PT (1) PT973505E (de)
SK (1) SK282905B6 (de)
TR (1) TR199901987T2 (de)
UA (1) UA63939C2 (de)
WO (1) WO1998036735A1 (de)
ZA (1) ZA981354B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9804192D0 (sv) * 1998-12-03 1998-12-03 Scotia Lipidteknik Ab New formulation
US6075045A (en) * 1999-04-28 2000-06-13 Ajinomoto Co., Inc. Method of treating paralysis of the extremities caused by cerebral infarction
JP4894119B2 (ja) * 2001-09-26 2012-03-14 日油株式会社 脂肪酸含有リポソーム分散液
US20040115226A1 (en) * 2002-12-12 2004-06-17 Wenji Li Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same
ES2254046T1 (es) * 2003-01-17 2006-06-16 Threshold Pharmaceuticals, Inc. Tratamiento de hiperplasia prostatica benigna.
US20050238675A1 (en) * 2004-04-26 2005-10-27 Wenjie Li Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
CN113382719B (zh) * 2018-12-11 2023-10-31 迪斯拉普申实验室公司 用于递送治疗剂的组合物及其使用方法和制备方法
CN111759807B (zh) * 2019-04-01 2021-06-01 上海谷森医药有限公司 一种环孢素脂质体及其制备方法
EP3990433A4 (de) 2019-06-25 2023-07-26 Translatum Medicus Inc. Verfahren zur herstellung von 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropansäure und ihren derivaten

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1264668A (en) * 1984-06-20 1990-01-23 Pieter R. Cullis Extrusion techniques for producing liposomes
DE4038075C1 (en) * 1990-11-29 1992-03-19 B. Braun Melsungen Ag, 3508 Melsungen, De Encapsulating solid or liq. lipophilic agents - comprises mixing hydration medium with phospholipid increasing temp. to above soln. phase change temp. and adding remaining medium
IT1254995B (it) * 1992-06-24 1995-10-11 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
AT396755B (de) * 1992-07-09 1993-11-25 Oesko Gmbh Verfahren zum reinigen eines rauchgasstromes mit hilfe einer waschflüssigkeit
FR2716110B1 (fr) * 1994-02-16 1996-04-05 Roussel Uclaf Compositions cosmétiques ou pharmaceutiques comprenant des liposomes.
DE4430593C2 (de) * 1994-08-20 1999-01-14 Max Delbrueck Centrum Verfahren zur Herstellung von Liposomal verkapseltem Taxol
WO1996040064A1 (en) * 1995-06-07 1996-12-19 Nexstar Pharmaceuticals, Inc. Liposomal cyclosporin formulations as agents for immunosuppression and multiple drug resistant indications

Also Published As

Publication number Publication date
WO1998036735A1 (en) 1998-08-27
JP4299369B2 (ja) 2009-07-22
EA002281B1 (ru) 2002-02-28
AR011682A1 (es) 2000-08-30
HU225594B1 (en) 2007-05-02
CA2285985A1 (en) 1998-08-27
IT1289939B1 (it) 1998-10-19
BG64367B1 (bg) 2004-12-30
ITMI970363A1 (it) 1998-08-20
CN1135969C (zh) 2004-01-28
HUP0000910A2 (hu) 2000-10-28
PL335208A1 (en) 2000-04-10
CA2285985C (en) 2008-01-29
DE69821001T2 (de) 2004-11-11
KR20000075480A (ko) 2000-12-15
PL190987B1 (pl) 2006-02-28
PT973505E (pt) 2004-05-31
CZ292699A3 (cs) 2000-01-12
IL131354A0 (en) 2001-01-28
BG103739A (en) 2000-06-30
SK282905B6 (sk) 2003-01-09
ES2213894T3 (es) 2004-09-01
EA199900750A1 (ru) 2000-04-24
KR100515249B1 (ko) 2005-09-16
GEP20022751B (en) 2002-08-26
DK0973505T3 (da) 2004-05-03
ZA981354B (en) 1998-08-17
ATE257374T1 (de) 2004-01-15
AU740619B2 (en) 2001-11-08
EP0973505B1 (de) 2004-01-07
HUP0000910A3 (en) 2000-11-28
EP0973505A1 (de) 2000-01-26
UA63939C2 (uk) 2004-02-16
SK111199A3 (en) 2000-06-12
JP2001519775A (ja) 2001-10-23
CN1255057A (zh) 2000-05-31
AU6398798A (en) 1998-09-09
CZ296700B6 (cs) 2006-05-17
US6337087B1 (en) 2002-01-08
TR199901987T2 (xx) 1999-11-22
IL131354A (en) 2010-06-30

Similar Documents

Publication Publication Date Title
BR9912979B1 (pt) composição farmacêutica administrável oralmente, tablete de mascar, cápsula e uso de chitosan.
EP0645136A3 (de) Pharmazeutisches Präparat des Typs: physiologisch aktive Substanz mit verlängerter Freisetzung.
DE69001730D1 (de) Pastenfoermige, waesserige pharmazeutische zusammensetzungen.
DE69900162D1 (de) Arzneimittel enthaltend Oxaliplatin
MX9203480A (es) Formulaciones medicinales en aereosol.
BRPI9810519B1 (pt) derivados de 4''-substituìdo-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos.
DE3786481D1 (de) Topische antimikrobielle arzneimittel.
DE69018647D1 (de) Arzneimittel.
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
NO2009028I1 (no) Kinazolin-derivater, anvendelse og fremstilling derav, samt farmasøytisk preparat
IS1950B (is) Arýlsúlfonýlamínó hýdroxamsýruafleiður, notkun þeirra, ásamt lyfjablöndum
IS5130A (is) Arýlsúlfonýlamínó hýdroxamsýruafleiður, notkun þeirra, ásamt lyfjablöndum
NL194239B (nl) Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten.
CY2359B1 (en) Pharmaceutical formulation.
NO985368L (no) Substituerte imidazolidinderivater, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende forbindelsene
ATE237320T1 (de) Venlafaxinhaltiges arzneimittel mit verlängerter wirkstoffabgabe
CA2341297A1 (en) Dosage form comprising liquid formulation
DE69821001D1 (de) Wässriges arzneimittel, das einen in wasser sehr schwerlöslichen aktivbestandteil enthält
ZA200203294B (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them.
DZ1926A1 (fr) Formulations pharmaceutiques.
NO980471L (no) Benzensulfonamidderivater, fremstilling derav og terapautiske anvendelser derav
FI923371A0 (fi) En farmaceutisk formulation.
DE69914472D1 (de) Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung
DE69402409D1 (de) Vismia extrakt enthaltende kosmetische oder pharmazeutische zubereitung insbesonders dermatologisch.
DE50008259D1 (de) Feste pharmazeutische zubereitungen mit nanosols aus chitosan, sowie deren herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition